期刊
CANCER CELL
卷 24, 期 4, 页码 438-449出版社
CELL PRESS
DOI: 10.1016/j.ccr.2013.09.004
关键词
-
资金
- Howard Hughes Medical Institute
- Samuel Waxman Cancer Research Foundation
- [K08NS079485]
- [U54CA163155]
- [U01CA176287]
EGFRvIll, a frequently occurring mutation in primary glioblastoma, results in a protein product that cannot bind ligand, but signals constitutively. Deducing how EGFRvIll causes transformation has been difficult because of autocrine and paracrine loops triggered by EGFRvIll alone or in heterodimers with wild-type EGFR. Here, we document coexpression of EGFR and EGFRvIll in primary human glioblastoma that drives transformation and tumorigenesis in a cell-intrinsic manner. We demonstrate enhancement of downstream STAT signaling triggered by EGFR-catalyzed phosphorylation of EGFRvIll, implicating EGFRvIll as a substrate for EGFR. Subsequent phosphorylation of STAT3 requires nuclear entry of EGFRvIll and formation of an EGFRvIll-STAT3 nuclear complex. Our findings clarify specific oncogenic signaling relationships between EGFR and EGFRvIll in glioblastonna..
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据